Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D /R- transplant recipients (Q46427144)

22 December 2017

title

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D /R- transplant recipients (English)

1 reference

22 December 2017

0 references

Atul Humar

1

1 reference

22 December 2017

Tony Mazzulli

2

1 reference

22 December 2017

George Moussa

3

1 reference

22 December 2017

Raymund R Razonable

4

1 reference

22 December 2017

Carlos V Paya

5

1 reference

22 December 2017

Mark D Pescovitz

6

1 reference

22 December 2017

Emma Covington

7

1 reference

22 December 2017

Emma Alecock

8

1 reference

22 December 2017

Valganciclovir Solid Organ Transplant Study Group

9

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

American Journal of Transplantation

published in

1 reference

22 December 2017

volume

5

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

1065-1070

1 reference

22 December 2017

Infection in organ-transplant recipients

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8 T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2005.00797.X

10.1111/J.1600-6143.2005.00797.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017